Walleye Capital
ABVX

Walleye Capital’s Abivax ABVX Stock Holding History

Walleye Capital’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.22M Buy
31,632
+23,038
+268% +$2.61M 0.02% 931
2026
Q1 		$957K Sell
8,594
-14,515
-63% -$1.72M ﹤0.01% 2117
2025
Q4 		$3.12M Buy
+23,109
New +$2.52M 0.01% 1506
2025
Q2 		– Sell
-220,845
Closed -$1.38M – 4432
2025
Q1 		$1.38M Sell
220,845
-81,797
-27% -$554K 0.01% 1723
2024
Q4 		$2.22M Buy
302,642
+45,225
+18% +$416K 0.01% 1699
2024
Q3 		$2.97M Buy
257,417
+80,807
+46% +$968K 0.01% 1596
2024
Q2 		$2.33M Sell
176,610
-10,434
-6% -$149K ﹤0.01% 1959
2024
Q1 		$2.67M Buy
+187,044
New +$2.41M ﹤0.01% 1779

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $3.35B AUM 55.08% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Walleye Capital's ABVX Position: Q2 2026 in Review

Walleye Capital increased its Abivax (ABVX) stake by 268% in Q2 2026, buying an estimated $2.61M and bringing the position to 31,632 shares worth $4.22M. The position accounts for 0.02% of the portfolio, ranked #931.

Walleye Capital first reported a position in ABVX in Q1 2024 and has held it in 8 quarters since. 303 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • Walleye Capital held 31,632 shares of Abivax worth $4.22M as of Q2 2026.
  • Walleye Capital bought 23,038 Abivax shares in Q2 2026, an estimated $2.61M.
  • Abivax made up 0.02% of Walleye Capital's portfolio in Q2 2026, its #931 holding.
  • Walleye Capital first reported a position in Abivax in Q1 2024 and has held it in 8 quarters since.
  • 303 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.